BCWM LLC’s ETF Series Solutions Trust Range Cancer Therapeutics ETF CNCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-577,414
| Closed | -$6.92M | – | 62 |
|
|
2023
Q1 | $6.92M | Buy |
577,414
+25,830
| +5% | +$310K | 2.19% | 21 |
|
|
2022
Q4 | $7.57M | Buy |
551,584
+191,713
| +53% | +$2.63M | 2.49% | 14 |
|
|
2022
Q3 | $5.27M | Sell |
359,871
-254,056
| -41% | -$3.72M | 1.91% | 22 |
|
|
2022
Q2 | $9.33M | Buy |
613,927
+120,647
| +24% | +$1.83M | 3.18% | 6 |
|
|
2022
Q1 | $8.88M | Buy |
493,280
+241,743
| +96% | +$4.35M | 2.65% | 14 |
|
|
2021
Q4 | $5.99M | Sell |
251,537
-80,138
| -24% | -$1.91M | 1.76% | 23 |
|
|
2021
Q3 | $10.1M | Buy |
331,675
+7,607
| +2% | +$231K | 3% | 5 |
|
|
2021
Q2 | $10.3M | Buy |
324,068
+8,192
| +3% | +$261K | 3.05% | 4 |
|
|
2021
Q1 | $9.45M | Sell |
315,876
-26,921
| -8% | -$806K | 2.79% | 8 |
|
|
2020
Q4 | $10.9M | Buy |
342,797
+7,991
| +2% | +$253K | 3.24% | 5 |
|
|
2020
Q3 | $9.19M | Buy |
334,806
+3,154
| +1% | +$86.6K | 3.12% | 3 |
|
|
2020
Q2 | $8.98M | Buy |
331,652
+287
| +0.1% | +$7.77K | 3.22% | 2 |
|
|
2020
Q1 | $6.47M | Buy |
331,365
+104,259
| +46% | +$2.04M | 2.7% | 6 |
|
|
2019
Q4 | $5.32M | Buy |
227,106
+5,570
| +3% | +$131K | 1.9% | 20 |
|
|
2019
Q3 | $4.16M | Buy |
221,536
+3,398
| +2% | +$63.7K | 1.68% | 30 |
|
|
2019
Q2 | $4.61M | Buy |
218,138
+6,629
| +3% | +$140K | 1.84% | 22 |
|
|
2019
Q1 | $4.45M | Buy |
211,509
+131,167
| +163% | +$2.76M | 2% | 18 |
|
|
2018
Q4 | $15.2M | Sell |
80,342
-100,914
| -56% | -$19M | 0.72% | 56 |
|
|
2018
Q3 | $4.5M | Buy |
181,256
+17,627
| +11% | +$438K | 1.88% | 21 |
|
|
2018
Q2 | $3.95M | Buy |
163,629
+4,676
| +3% | +$113K | 1.73% | 27 |
|
|
2018
Q1 | $4.62M | Sell |
158,953
-3,533
| -2% | -$103K | 1.97% | 15 |
|
|
2017
Q4 | $3.86M | Sell |
162,486
-302
| -0.2% | -$7.18K | 1.58% | 30 |
|
|
2017
Q3 | $4.41M | Buy |
162,788
+620
| +0.4% | +$16.8K | 1.85% | 19 |
|
|
2017
Q2 | $3.74M | Buy |
162,168
+11,665
| +8% | +$269K | 1.66% | 27 |
|
|
2017
Q1 | $3.66M | Buy |
150,503
+14,537
| +11% | +$353K | 1.65% | 25 |
|
|
2016
Q4 | $2.89M | Buy |
+135,966
| New | +$2.89M | 1.34% | 36 |
|